What Checkmate Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 16 | Open-market sale · S | −95,800 | $10.45 | −$1M | 2,155,930 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 13 | Open-market sale · S | −35,850 | $10.45 | −$374K | 2,251,730 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 12 | Open-market sale · S | −124,525 | $10.39 | −$1.29M | 2,287,580 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 11 | Open-market sale · S | −17,700 | $10.38 | −$184K | 2,412,105 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 10 | Open-market sale · S | −18,676 | $10.38 | −$194K | 2,429,805 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 09 | Open-market sale · S | −17,600 | $10.37 | −$183K | 2,448,481 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 06 | Open-market sale · S | −48,334 | $10.37 | −$501K | 2,466,081 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 05 | Open-market sale · S | −20,743 | $10.37 | −$215K | 2,514,415 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 04 | Open-market sale · S | −37,500 | $10.37 | −$389K | 2,535,158 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 03 | Open-market sale · S | −79,475 | $10.37 | −$824K | 2,572,658 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | May 02 | Open-market sale · S | −153,700 | $10.38 | −$1.6M | 2,652,133 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 29 | Open-market sale · S | −69,230 | $10.38 | −$719K | 2,805,833 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 28 | Open-market sale · S | −73,400 | $10.38 | −$762K | 2,875,063 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 27 | Open-market sale · S | −47,396 | $10.38 | −$492K | 2,948,463 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 26 | Open-market sale · S | −64,683 | $10.38 | −$672K | 2,995,859 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 25 | Open-market sale · S | −27,668 | $10.39 | −$287K | 3,060,542 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 22 | Open-market sale · S | −37,430 | $10.39 | −$389K | 3,088,210 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 21 | Open-market sale · S | −62,200 | $10.38 | −$646K | 3,125,640 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 20 | Open-market sale · S | −85,611 | $10.39 | −$889K | 3,187,840 |
| venBio Global Strategic Fund Ii L.p. | 10% owner | Apr 19 | Open-market sale · S | −399,923 | $10.42 | −$4.17M | 3,273,451 |
Loading...